| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.62▼ | 1.61▲ | 1.61▲ | 1.57▲ | 1.42▲ |
| MA10 | 1.62▼ | 1.61▲ | 1.60▲ | 1.46▲ | 1.39▲ |
| MA20 | 1.59▲ | 1.52▲ | 1.50▲ | 1.39▲ | 1.46▲ |
| MA50 | 1.45▲ | 1.42▲ | 1.41▲ | 1.38▲ | 1.21▲ |
| MA100 | 1.41▲ | 1.39▲ | 1.37▲ | 1.46▲ | 2.05▼ |
| MA200 | 1.37▲ | 1.40▲ | 1.41▲ | 1.20▲ | 7.77▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.007▼ | 0.003▲ | 0.008▲ | 0.035▲ | 0.005▲ |
| RSI | 60.361▲ | 63.236▲ | 66.393▲ | 74.959▲ | 60.325▲ |
| STOCH | 59.298 | 60.403 | 67.561 | 67.769 | 38.904 |
| WILL %R | -45.000 | -28.125 | -14.516▲ | -14.865▲ | -31.818 |
| CCI | -2.393 | 51.412 | 61.875 | 130.243▲ | 146.151▲ |
|
Tuesday, October 27, 2026 03:29 AM
InMed Pharmaceuticals Inc. (INM) is in focus after a fresh update clarified the operating story and key market questions.
|
|
Monday, October 26, 2026 05:00 PM
InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseases with high ...
|
|
Monday, October 26, 2026 06:35 AM
IBM (NYSE:IBM) beat estimates as software growth accelerated and delayed mainframe deals closed, lifting its full-year free cash flow outlook.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 29/10/26 | 1.59 | 1.64 | 1.59 | 1.625 | 37,271 |
| 28/10/26 | 1.63 | 1.67 | 1.59 | 1.5992 | 40,653 |
| 27/10/26 | 1.59 | 1.68 | 1.5405 | 1.59 | 114,764 |
| 26/10/26 | 1.44 | 1.6214 | 1.41 | 1.59 | 293,334 |
| 23/10/26 | 1.321 | 1.54 | 1.32 | 1.44 | 125,900 |
| 22/10/26 | 1.36 | 1.375 | 1.33 | 1.33 | 8,292 |
| 21/10/26 | 1.32 | 1.3899 | 1.32 | 1.36 | 26,405 |
| 20/10/26 | 1.345 | 1.3887 | 1.34 | 1.34 | 38,104 |
| 19/10/26 | 1.32 | 1.39 | 1.32 | 1.3654 | 38,467 |
| 16/10/26 | 1.32 | 1.34 | 1.32 | 1.32 | 4,339 |
|
|
||||
|
|
||||
|
|